首页> 外文期刊>The Journal of craniofacial surgery >Effect of Induction Chemotherapy on Changes of Laminin and Syndecan Expression in Oral Squamous Cell Carcinomas: A Prospective, Randomized, Clinicopathologic and Immunohistochemical Study.
【24h】

Effect of Induction Chemotherapy on Changes of Laminin and Syndecan Expression in Oral Squamous Cell Carcinomas: A Prospective, Randomized, Clinicopathologic and Immunohistochemical Study.

机译:诱导化学疗法对口腔鳞癌中层粘连蛋白和Syndecan表达变化的影响:一项前瞻性,随机,临床病理和免疫组织化学研究。

获取原文
获取原文并翻译 | 示例
           

摘要

Sixty patients with tumors of the floor of the mouth or of the tongue (T2N0-1-2M0) were randomized into three treatment groups. The first two groups participated in low-dose inductive chemotherapy, surgery, and then radiotherapy, whereas the third control group underwent only surgery and radiotherapy. In all three groups, studies were made of the stage, grade, sex, localization, extents of expression of the pretreatment laminin and syndecan-1 and the cancer specific survival rate, and the correlations among these. The response to neoadjuvant chemotherapy was assessed by means of a method that we developed, involving measurement of the degree of histologic regression observed in response to chemotherapy. Immunohistochemical methods were applied to investigate the changes in degree of expression of laminin and syndecan-1 in response to the medication and their correlations with the survival. As concerns the overall tumorfree survival rate, a significant difference was not found between the two chemotherapeutic groups. However, there was a significant difference between the survival indices of those who participated in cytostatic treatment (70%) and the control group (40%). In the clinical and immunohistochemical examinations, the initial laminin and syndecan-1 levels obtained from biopsy samples could be used as prognostic factors. Our model measuring the extent of histologic regression clearly demonstrated that the survival indices of the patients who responded to the neoadjuvant cytostatic treatment with adequate tissue regression were better than those of the patients who responded to the treatment to only a decreased extent or not at all. The changes in the expressions of laminin and syndecan-1 in response to cystostatic treatment proved to be important predictive factors. The increase or stagnation of these clearly forecast a good prognosis, whereas their decrease was a definite indication of poor prognosis.
机译:将60例口腔或舌底肿瘤(T2N0-1-2M0)患者随机分为三个治疗组。前两组参加小剂量诱导化疗,手术,然后放疗,而第三组仅接受手术和放疗。在所有这三组中,均对预处理层粘连蛋白和syndecan-1的表达,阶段,等级,性别,定位,表达范围以及癌症的特定存活率及其相关性进行了研究。对新辅助化疗的反应通过我们开发的方法进行评估,该方法包括测量对化疗反应观察到的组织学退化程度。免疫组织化学方法用于研究层粘连蛋白和syndecan-1表达水平随药物反应的变化及其与生存率的关系。至于总的无瘤生存率,两组之间未发现显着差异。但是,参与细胞抑制治疗的患者(70%)和对照组(40%)的生存指数之间存在显着差异。在临床和免疫组织化学检查中,从活检样本中获得的初始层粘连蛋白和syndecan-1水平可以用作预后因素。我们测量组织学消退程度的模型清楚地表明,对新辅助细胞抑制治疗有效的组织消退有反应的患者的生存指数要好于仅对程度降低或根本没有反应的患者的生存指数。层囊收缩剂处理后层粘连蛋白和syndecan-1表达的变化被证明是重要的预测因素。这些疾病的增加或停滞显然预示了良好的预后,而其减少则预示了不良的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号